No significant differences in the number of CD3+, CD4+, CD8+, and CD103+ lymphocytes were observed between the center and the periphery of ccRCC tumors or between organ-confined (pT1/2) and non-organ-confined (pT3/4) tumors. This evidence concerns the gene CD4 and nonpapillary renal cell carcinoma.